Ayn. Schouten-van Meeteren et al., Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay, CANCER, 92(11), 2001, pp. 2933-2940
Background. Retinoblastoma is frequently treated with chemotherapy to facil
itate intraocular therapy, as well as to diminish or delay radiotherapy in
invasive disease. It is also used more extensively in patients with dissemi
nation to the central nervous system and/or the bone marrow. Once the disea
se has spread, the prognosis is poor. Radiotherapy is effective in ocular r
etinoblastoma, but is associated with facial deformation and a higher chanc
e for second primary tumors in the irradiation field. These sequelae emphas
ize the need to determine more effective chemotherapy schedules and local t
reatment. The aim of this study is to investigate the relation between in v
itro drug resistance for ten cytostatic drugs and histopathologic features
in primary retinoblastoma.
Materials and methods. Forty-four fresh samples of primary retinoblastoma w
ere tested for in vitro drug resistance using the 3-[4,5-dimethylthiazol-2y
l]-2,5-diphenyl tetrazolium. bromide (MTT) assay. The histopathologic featu
res for differentiation, invasion and intra-ocular extension, necrosis, mit
osis, and apoptosis were scored.
Results. The differentiation of the tumors revealed 24 poorly differentiate
d, 14 intermediately differentiated, and 6 well differentiated tumors. Tumo
r infiltration showed 3 minimal and 3 massive choroideal invasions, as well
as 21 prelaminary and 2 postlaminary optic nerve invasions. The tumor was
unifocal in 16 eyes and multifocal in 28 eyes, with extensive retinal invol
vement in 10 eyes and tumor seeding in 21 eyes. The MTT assay was successfu
l in 82% of the samples after enzymatic handling of the tumor cells was omi
tted. Undifferentiated tumors were more sensitive to carboplatin (p=0.034)
and doxorubicin (p=0.025), thiotepa (p=0.051) and ifosfamide (p=0.075) in c
omparison to differentiated tumors. Type of retinal involvement, invasion,
focality, and seeding did not show a relationship with drug resistance. Cal
cified tumors were more resistant to actinomycin D and ifosfamide and more
sensitive to vincristine; conversely, apoptotic tumors were more sensitive
to ifosfamide and more resistant to vincristine (p=0.027). Necrotic tumors
were more sensitive to actinomycin D (p=0.004), and mitotic tumors were mor
e sensitive to idarubicin (p=0.026). In 90% of the tumors extreme drug resi
stance to cytarabin was present.
Conclusions. In retinoblastoma many histopathologic features are related to
in vitro drug resistance. Undifferentiated tumors are more sensitive to se
veral cytostatic drugs. Calcification and apoptosis show an inverse relatio
n with invitro drug resistance to ifosfamide and vincristine. Extreme drug
resistance to cytarabin is observed, this drug should not be used in retino
blastoma treatment. Cancel, 2001; 92:2933-40. (C) 2001 American Cancer Soci
ety.